Role of functional assessment in asthma and COPD

A. Celi (Pisa, Italy)

Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Number: 4
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Celi (Pisa, Italy). Role of functional assessment in asthma and COPD. ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Potential usefulness of phenotyping in asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Role of activated complement in COPD exacerbation recovery
Source: International Congress 2014 – Comorbidities
Year: 2014


Targeting traits in asthma and COPD
Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!
Year: 2021


Mechanisms in COPD compared with asthma
Source: Breathe 2008; 5: 134-144
Year: 2008

Changes in cognitive status during acute exacerbation of COPD
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015


Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014

Identifying asthma features in severe COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




Defining asthma and COPD: differential diagnosis
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018


Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012

Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD
Source: ERJ Open Res, 7 (1) 00828-2020; 10.1183/23120541.00828-2020
Year: 2021



Targeting the epigenome in asthma and COPD
Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Year: 2013


Assessment of a disease management program for patients with asthma or COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 19s
Year: 2005

The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014


Contribution of respiratory function in asthma
Source: International Congress 2018 – Asthma and drugs
Year: 2018

Relationship of lung function to asthma severity in asthmatic families
Source: Eur Respir J 2005; 26: Suppl. 49, 397s
Year: 2005

Role of symptom assessment and spirometry in early COPD detection in Indian population
Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Year: 2009

Relation between COPD assessment test"CATÔ" and functional parameters and quality of life in COPD patients
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012

Characteristics of bronchial brush-biopsies at different etiology of COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 410s
Year: 2004

Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016